
Suven Life Sciences Share Price
NSE: SUVEN
|BSE: 530239
|Pharmaceuticals
₹226.99
+₹1.62 (0.72%) Last updated on 24 Jun, 2025 | 15:29 ISTSuven Life Sciences Overview
Market cap | Open ₹225.00 | Prev. Close ₹225.37 |
Circuit range ₹237.19 - ₹214.60 | Day range ₹225.00 - ₹232.50 | Year range ₹99.10 - ₹271.72 |
Volume 1,23,661 | Avg. traded ₹227.48 | Revenue (12m) ₹7 Crs |
About Suven Life Sciences
Suven Life Sciences Limited is an India-based biopharmaceutical company, which is engaged in drug discovery and development of new chemical entities (NCEs) in central nervous system (CNS) disorders targeting unmet medical needs, globally. The Company's lead clinical-stage assets include Masupirdine (Pure 5-HT 6 receptor antagonist), Samelisant (Histamine 3 receptor inverse agonist) and Ropanicant (a4b2 antagonist). Masupirdine is an ongoing phase III study for agitation and aggression in Alzheimer's type dementias in North America and Europe. Samelisant is a study on the treatment of excessive daytime sleepiness (EDS) in adult narcolepsy patients with and without cataplexy. Ropanicant is an ongoing screening for Phase II open label study for moderate to severe major depressive disorder in United States. Its other clinical-stage assets include Usmarapride (5-HT4 receptor agonist), SUVN-I6107 (True muscarinic M1 positive allosteric modulator) and SUVN-D1044 (5-HT4 receptor agonist).
Suven Life Sciences Share Price Chart
Please wait...
Suven Life Sciences Key Indicators
P/E ratio | P/B ratio 46.47 | ROE -0.94% |
ROCE -1.03% | Dividend yield -- | Debt/Equity ratio |
EPS -0.37 |
Investment Checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst Ratings:
100%
Hold
0%
Sell
0%
This analysis is based on the reviews of 1 experts in the last 7 days
Suven Life Sciences Financial Ratios
Operating profit margin-83.17% | Net profit margin-68.49% |
ROE-0.94% | ROA-0.89% |
ROCE-1.03% |
Quick ratio51.55 | Current ratio51.7 |
Interest coverage-36.47 | Asset turnover0.01 |
Debt to Equity0 |
P/E ratio0 | P/B ratio46.47 |
EV / EBITDA-207.8 | |
Dividend yield0% |
Revenue Statement
All values are in ₹ Crores (Cr)
Year | Revenue | Operating Profit | Net Profit |
---|---|---|---|
Mar-24 | ₹11.69 | ₹-106.73 | ₹-105.08 |
Mar-23 | ₹13.54 | ₹-117.31 | ₹-118.27 |
Mar-22 | ₹11.84 | ₹-120.65 | ₹-122 |
Mar-21 | ₹13.48 | ₹-72.19 | ₹-72.15 |
Cash Flow
All values are in ₹ Crores (Cr)
Year | Operating | Investing | Financing |
---|---|---|---|
Mar-24 | ₹-115.47 | ₹-1.05 | |
Mar-23 | ₹-115.98 | ₹-247.81 | |
Mar-22 | ₹-127.54 | ₹-22.23 | |
Mar-21 | ₹-96.02 |
Balance Sheet
All values are in ₹ Crores (Cr)
Period | Total Asset | Total Liability |
---|---|---|
Mar-24 | ₹284.90 | ₹14.86 |
Mar-23 | ₹482.81 | ₹107.49 |
Mar-22 | ₹201.93 | ₹105.79 |
Mar-21 | ₹222.32 | ₹114.31 |
Suven Life Sciences Share Price History
Day | Open | Close | Change % |
---|---|---|---|
24-Jun-25 | ₹225.00 | ₹225.90 | |
23-Jun-25 | ₹221.02 | ₹225.37 | -0.84% |
20-Jun-25 | ₹226.23 | ₹227.29 | |
19-Jun-25 | ₹237.61 | ₹226.23 | -3.84% |
18-Jun-25 | ₹240.00 | ₹235.26 | -0.71% |
17-Jun-25 | ₹248.00 | ₹236.95 | -4.64% |
16-Jun-25 | ₹237.60 | ₹248.48 | |
13-Jun-25 | ₹250.00 | ₹236.03 | -9.42% |
Stocks Similar to Suven Life Sciences
Stock Name | Price | Change % |
---|---|---|
Bajaj Healthcare | ₹528.60 | +₹4.50 (0.86%) |
Bliss GVS Pharma | ₹148.02 | -₹0.52 (-0.35%) |
Kopran | ₹178.68 | +₹2.99 (1.70%) |
Medicamen Biotech | ₹394.10 | -₹3.50 (-0.88%) |
NGL Fine Chem | ₹1,014.90 | +₹19.90 (2.00%) |
ORCHID PHARMA | ₹698.00 | +₹14.45 (2.11%) |
Panacea Biotec | ₹416.30 | +₹1.25 (0.30%) |
SMS Pharmaceuticals | ₹233.50 | +₹1.80 (0.78%) |
Zota Health Care | ₹957.75 | +₹26.00 (2.79%) |
Popular Stocks
Stock Name | Price | Change % |
---|---|---|
IDFC First Bank | ₹72.02 | +₹1.01 (1.42%) |
Indian Railway Finance Corp | ₹138.62 | +₹1.64 (1.20%) |
ITC | ₹414.35 | +₹0.45 (0.11%) |
JIO FIN SERVICES LTD | ₹300.80 | +₹7.65 (2.61%) |
Suzlon | ₹64.39 | +₹1.60 (2.55%) |
Tata Motors | ₹673.65 | +₹2.40 (0.36%) |
Tata Power | ₹398.45 | +₹5.45 (1.39%) |
Tata Steel | ₹154.79 | +₹2.36 (1.55%) |
Vodafone Idea | ₹6.86 | +₹0.31 (4.73%) |
YES Bank | ₹19.97 | +₹0.09 (0.45%) |
Suven Life Sciences News
FAQs on Suven Life Sciences
What is the share price of Suven Life Sciences today?
Suven Life Sciences share price is ₹ 226.99 as on 24 Jun, 2025 | 15:29 IST.
What are the high & low stock price of Suven Life Sciences today?
Suven Life Sciences stock price hit a high of ₹ 232.50 and low of ₹ 225.00 as on 24 Jun, 2025 | 15:29 IST.
What is the market cap of Suven Life Sciences?
The market cap of Suven Life Sciences is ₹ 4,914.73 Crores as on 24 Jun, 2025 | 15:29 IST.
What are the the 52-week high and low share prices of Suven Life Sciences stock on the NSE?
52-week high stock Price of Suven Life Sciences is ₹ 271.72 and Low Price is ₹ 99.10 as on 24 Jun, 2025 | 15:29 IST.
What are the stock symbols of Suven Life Sciences?
The stock symbol of Suven Life Sciences is NSE: SUVEN on the NSE, BSE: 530239 on the BSE, and the ISIN is INE495B01038.
Can I buy Suven Life Sciences shares on Holidays?
No, shares of Suven Life Sciences or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Suven Life Sciences shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What are the returns on Suven Life Sciences shares?
The historical returns for Suven Life Sciences shares are 126.87 for 1 year, 193.83 for 3 year and 478.61 for 5 year.